Evidence map›Paper›PMID 32782517›Full record

ArticleExperimental and therapeutic medicine2020

CD271

Felician Stancioiu, Georgios Z Papadakis, George Lazopoulos, Demetrios A Spandidos, Aristidis Tsatsakis, Marius Floroiu, Corin Badiu

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental and therapeutic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Preclinical and clinical evidence of IGF-1 as a prognostic marker and acute intervention with ischemic stroke.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Felician StancioiuBio-Forum Foundation, 030121 Bucharest, Romania.
Georgios Z PapadakisDepartment of Radiology, Medical School, University of Crete, 71003 Heraklion, Greece.
George LazopoulosDepartment of Cardiothoracic Surgery, University General Hospital of Heraklion, 71003 Heraklion, Greece.
Demetrios A SpandidosLaboratory of Clinical Virology, Medical School, University of Crete, 71003 Heraklion, Greece.
Aristidis TsatsakisLaboratory of Toxicology, Medical School, University of Crete, 71003 Heraklion, Greece.
Marius FloroiuCardiovascular Surgery Department, Angiomedica Hospital, 020657 Bucharest, Romania.
Corin BadiuCI Parhon Institute of Endocrinology, 011863 Bucharest, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with chronic stroke have currently little hope for motor improvement towards regaining independent activities of daily living; stem cell treatments offer a new treatment option and needs to be developed. Patients with chronic stroke (more than 3 months prior to stem cell treatment, mean 21.2 months post-stroke) were treated with CD271

Indexed as

aphasia treatmentCD271+ stem cellschronic strokeneural stem cellsspasticity treatmentstem cell treatmentstroke treatment

Identifiers

PMID32782517
PMCPMC7401309

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.